Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:507-509
doi: 10.1161/CIRCRESAHA.108.173013
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VanBavel, E.
Right arrow Articles by Bakker, E. N.T.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VanBavel, E.
Right arrow Articles by Bakker, E. N.T.P.
Related Collections
Right arrowRelated Article
(Circulation Research. 2008;102:507.)
© 2008 American Heart Association, Inc.


Editorials

A Vascular Bone Collector

Arterial Calcification Requires Tissue-Type Transglutaminase

Ed VanBavel, Erik N.T.P. Bakker

From the Department of Medical Physics, Academic Medical Center, The Netherlands.

Correspondence to Ed VanBavel, Department of Medical Physics, Academic Medical Center, The Netherlands, PO Box 22700, 1100 DE Amsterdam, The Netherlands. E-mail E.vanbavel@amc.uva.nl



See related article, pages 529–537


Key Words: transglutaminase • atherosclerosis • smooth muscle cell • calcification


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Calcification of the arterial wall occurs in, among others, atherosclerosis and aging. The role of calcification in plaque stability is subject of ongoing discussion; media calcification in aging and diabetes increases stiffness and pulse pressure.1 It is now clear that calcification is not simply a passive process but, rather, is tightly regulated, involving induction of an osteochondrogenic phenotype in the vascular smooth muscle cells (VSMCs) and control of expression and activity of factors promoting and inhibiting calcium deposition. In this issue of Circulation Research, Johnson et al2 provide evidence that transglutaminases (Tgases), cross-linking enzymes with recently discovered vascular functions, are required for inducing the vascular calcification process.

Tgases are multifunctional enzymes acting in the cell, at the cell surface, or as released enzymes. Their most prominent feature is the covalent cross-linking of proteins.3 The glutamine–lysine cross-links, either within or between proteins, result in the stabilization of extracellular matrices and the binding of signaling molecules, such as osteopontin, to the matrix but also the prolonged activation of angiotensin II receptors through dimerization.4 Cell surface Tgases are involved in cell adhesion through integrin clustering and function as coreceptors in the binding to fibronectin.5 The Tgase family consists of 9 members, of which TG1, TG2, and the coagulation factor XIIIA are expressed in the arterial wall.6 The tissue-type Tgase studied here (TG2) fulfills both cross-linking activities and G protein functions. Mice deficient in TG2 have no obvious cardiovascular phenotype. However, when challenged, arteries show impaired capacity to undergo inward remodeling in response . . . [Full Text of this Article]


Related Article:

Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells
Kristen A. Johnson, Monika Polewski, and Robert A. Terkeltaub
Circ. Res. 2008 102: 529-537. [Abstract] [Full Text] [PDF]